Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 646

1.

Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation.

Rickards KJ, Andrews MJ, Waterworth TH, Alexander GB, Cunningham FM.

J Vet Pharmacol Ther. 2003 Aug;26(4):277-82.

PMID:
12887610
3.
5.
6.

Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells.

Banner KH, Hoult JR, Taylor MN, Landells LJ, Page CP.

Biochem Pharmacol. 1999 Nov 1;58(9):1487-95.

PMID:
10513992
7.
8.

Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.

Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW.

Biochem Pharmacol. 2004 Apr 15;67(8):1559-67.

PMID:
15041473
9.
11.

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.

Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y, Hidaka H.

Biochem Pharmacol. 2000 Feb 15;59(4):347-56.

PMID:
10644042
12.

Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.

Alves AC, Pires AL, Cruz HN, Serra MF, Diaz BL, Cordeiro RS, Lagente V, Martins MA.

Eur J Pharmacol. 1996 Sep 19;312(1):89-96.

PMID:
8891583
13.

Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.

Moon E, Lee R, Near R, Weintraub L, Wolda S, Lerner A.

Clin Cancer Res. 2002 Feb;8(2):589-95.

14.

Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.

Mazurov AV, Menshikov MYu, Leytin VL, Tkachuk VA, Repin VS.

FEBS Lett. 1984 Jul 9;172(2):167-71.

15.

Xanthines inhibit human platelet aggregation induced by platelet-activating factor.

Misso NL, Thompson PJ.

Clin Exp Pharmacol Physiol. 1992 Aug;19(8):599-602.

PMID:
1526066
16.
17.

Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.

O'Donnell JM, Frith S.

Pharmacol Biochem Behav. 1999 May;63(1):185-92.

PMID:
10340540
18.

Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.

Simpson AW, Reeves ML, Rink TJ.

Biochem Pharmacol. 1988 Jun 15;37(12):2315-20.

PMID:
2455518
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk